|
Market Closed -
Nasdaq
21:00:00 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 13.33 USD | -1.26% |
|
+6.30% | +62.96% |
Company Valuation: ORIC Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 578.9 | 264.8 | 501.9 | 569.5 | 796.6 | 1,382 | - | - |
| Change | - | -54.26% | 89.55% | 13.47% | 39.89% | 73.44% | - | - |
| Enterprise Value (EV) | 578.9 | 264.8 | 266.8 | 569.5 | 751 | 1,382 | 1,382 | 1,382 |
| Change | - | -54.26% | 0.78% | 113.42% | 31.87% | 83.99% | 0% | 0% |
| P/E | -7.1x | -2.62x | -4.69x | -4.41x | -5.56x | -8.76x | -7.93x | -7.2x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.3x | 0.4x | 0.66x | 0.3x | -2.5x | -0.8x | -0.7x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 451x |
| EV / Revenue | - | - | - | - | - | - | - | 451x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -8.56x | -8.35x | -9.66x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -7.71x | -6.59x | -5.79x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -10.2x | -8.2x | -6.79x |
| FCF Yield | -10.4% | -29.2% | -17.2% | -20% | -14% | -9.77% | -12.2% | -14.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.07 | -2.25 | -1.96 | -1.83 | -1.47 | -1.521 | -1.68 | -1.852 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 3.064 |
| EBITDA 1 | -77.97 | -90.8 | -109.7 | -141.8 | -141.8 | -161.4 | -165.6 | -143 |
| EBIT 1 | -78.87 | -91.77 | -110.8 | -142.9 | -143 | -179.1 | -209.6 | -238.7 |
| Net income 1 | -78.72 | -89.12 | -100.7 | -127.8 | -129.5 | -166.6 | -200.3 | -239.6 |
| Net Debt | - | - | -235 | - | -45.67 | - | - | - |
| Reference price 2 | 14.70 | 5.89 | 9.20 | 8.07 | 8.18 | 13.33 | 13.33 | 13.33 |
| Nbr of stocks (in thousands) | 39,382 | 44,953 | 54,552 | 70,567 | 97,389 | 103,653 | - | - |
| Announcement Date | 21/03/22 | 16/03/23 | 11/03/24 | 18/02/25 | 23/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.88x | - | - | -.--% | 1.38B | |
| 21.8x | 7.74x | 15.55x | 1.36% | 74.18B | |
| 31.81x | 9.18x | 28.6x | 0.04% | 59.55B | |
| -73.75x | 14.26x | -68.76x | -.--% | 25.84B | |
| -15.46x | 5.96x | -7.5x | -.--% | 24.73B | |
| 28.48x | 5.36x | 17.82x | -.--% | 20.87B | |
| 43.75x | 16.03x | 32.53x | 0.34% | 15.32B | |
| 17.96x | 5.35x | 12.5x | -.--% | 14.06B | |
| -14.82x | 3341.5x | -17.09x | -.--% | 13.12B | |
| -82.17x | 7.51x | -62.2x | -.--% | 11.85B | |
| Average | -5.13x | 379.21x | -5.39x | 0.17% | 26.09B | |
| Weighted average by Cap. | 5.98x | 177.28x | 3.77x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORIC Stock
- Valuation ORIC Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
